225 related articles for article (PubMed ID: 34361031)
21. The prognostic potential of long noncoding RNA HOTAIR expression in human digestive system carcinomas: A meta-analysis.
Abdeahad H; Avan A; Pashirzad M; Khazaei M; Soleimanpour S; Ferns GA; Fiuji H; Ryzhikov M; Bahrami A; Hassanian SM
J Cell Physiol; 2019 Jul; 234(7):10926-10933. PubMed ID: 30569489
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Value of FOXM1 in Patients with Malignant Solid Tumor: A Meta-Analysis and System Review.
Dai J; Yang L; Wang J; Xiao Y; Ruan Q
Dis Markers; 2015; 2015():352478. PubMed ID: 26451068
[TBL] [Abstract][Full Text] [Related]
23. Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer.
Cao M; Yie SM; Liu J; Ye SR; Xia D; Gao E
Tissue Antigens; 2011 Aug; 78(2):120-8. PubMed ID: 21726203
[TBL] [Abstract][Full Text] [Related]
24. Implication of Soluble HLA-G and HLA-G +3142G/C Polymorphism in Breast Cancer Patients Receiving Adjuvant Therapy in Tanzania.
Adolf IC; Akan G; Mselle TF; Dharsee N; Namkinga LA; Atalar F
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3465-3472. PubMed ID: 31759373
[TBL] [Abstract][Full Text] [Related]
25. Expression of major histocompatibility class I and class II antigens and intercellular adhesion molecule-1 on operable non-small cell lung carcinomas: frequency and prognostic significance.
Passlick B; Izbicki JR; Simmel S; Kubuschok B; Karg O; Habekost M; Thetter O; Schweiberer L; Pantel K
Eur J Cancer; 1994; 30A(3):376-81. PubMed ID: 8204362
[TBL] [Abstract][Full Text] [Related]
26. [Research progress on HLA-G in non-small cell lung cancer].
Li R; Guo Z; Zhang X; Xiao L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Feb; 40(2):174-178. PubMed ID: 38284259
[TBL] [Abstract][Full Text] [Related]
27. Association between HLA-G 3'UTR 14-bp ins/del polymorphism and susceptibility to breast cancer.
Eskandari-Nasab E; Hashemi M; Hasani SS; Omrani M; Taheri M; Mashhadi MA
Cancer Biomark; 2013; 13(4):253-9. PubMed ID: 24240586
[TBL] [Abstract][Full Text] [Related]
28. PD-L1 Expression, Tumor Mutational Burden, and Cancer Gene Mutations Are Stronger Predictors of Benefit from Immune Checkpoint Blockade than HLA Class I Genotype in Non-Small Cell Lung Cancer.
Negrao MV; Lam VK; Reuben A; Rubin ML; Landry LL; Roarty EB; Rinsurongkawong W; Lewis J; Roth JA; Swisher SG; Gibbons DL; Wistuba II; Papadimitrakopoulou V; Glisson BS; Blumenschein GR; Lee JJ; Heymach JV; Zhang J
J Thorac Oncol; 2019 Jun; 14(6):1021-1031. PubMed ID: 30780001
[TBL] [Abstract][Full Text] [Related]
29. MUTYH-associated polyposis carcinomas frequently lose HLA class I expression - a common event amongst DNA-repair-deficient colorectal cancers.
de Miranda NF; Nielsen M; Pereira D; van Puijenbroek M; Vasen HF; Hes FJ; van Wezel T; Morreau H
J Pathol; 2009 Sep; 219(1):69-76. PubMed ID: 19462419
[TBL] [Abstract][Full Text] [Related]
30. Expression and change of miR-199b-5p, s HLA-G in thyroid carcinoma.
Tan B; Guo J; Wang L; Wang L; Gan X; Chen B
Exp Mol Pathol; 2021 Jun; 120():104643. PubMed ID: 33932399
[TBL] [Abstract][Full Text] [Related]
31. Human leukocyte antigen-G (HLA-G) expression plays an important role in the diagnosis and grading of endometrial cancer.
Bai Y; Liu W; Xie Y; Liang J; Wang F; Li C
J Obstet Gynaecol; 2022 May; 42(4):641-647. PubMed ID: 34382498
[TBL] [Abstract][Full Text] [Related]
32. HLA-G/sHLA-G and HLA-G-Bearing Extracellular Vesicles in Cancers: Potential Role as Biomarkers.
Li P; Wang N; Zhang Y; Wang C; Du L
Front Immunol; 2021; 12():791535. PubMed ID: 34868081
[TBL] [Abstract][Full Text] [Related]
33. In vivo evidence that secretion of HLA-G by immunogenic tumor cells allows their evasion from immunosurveillance.
Loumagne L; Baudhuin J; Favier B; Montespan F; Carosella ED; Rouas-Freiss N
Int J Cancer; 2014 Nov; 135(9):2107-17. PubMed ID: 24623585
[TBL] [Abstract][Full Text] [Related]
34. Biology of the immunomodulatory molecule HLA-G in human liver diseases.
Amiot L; Vu N; Samson M
J Hepatol; 2015 Jun; 62(6):1430-7. PubMed ID: 25772038
[TBL] [Abstract][Full Text] [Related]
35. HLA-G Expression is Associated with an Unfavorable Prognosis of Oral Squamous Cell Carcinoma.
Imani R; Seyedmajidi M; Ghasemi N; Moslemi D; Shafaee S; Bijani A
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2527-2533. PubMed ID: 30256047
[TBL] [Abstract][Full Text] [Related]
36. Human Leukocyte Antigen G Polymorphism and Expression Are Associated with an Increased Risk of Non-Small-Cell Lung Cancer and Advanced Disease Stage.
Ben Amor A; Beauchemin K; Faucher MC; Hamzaoui A; Hamzaoui K; Roger M
PLoS One; 2016; 11(8):e0161210. PubMed ID: 27517300
[TBL] [Abstract][Full Text] [Related]
37. GPER mediated estradiol reduces miR-148a to promote HLA-G expression in breast cancer.
Tao S; He H; Chen Q; Yue W
Biochem Biophys Res Commun; 2014 Aug; 451(1):74-8. PubMed ID: 25063027
[TBL] [Abstract][Full Text] [Related]
38. Human leukocyte antigen-G (HLA-G) as a marker for diagnosis, prognosis and tumor immune escape in human malignancies.
Yie SM; Hu Z
Histol Histopathol; 2011 Mar; 26(3):409-20. PubMed ID: 21210353
[TBL] [Abstract][Full Text] [Related]
39. Expression of classical human leukocyte antigen class I antigens, HLA-E and HLA-G, is adversely prognostic in pancreatic cancer patients.
Hiraoka N; Ino Y; Hori S; Yamazaki-Itoh R; Naito C; Shimasaki M; Esaki M; Nara S; Kishi Y; Shimada K; Nakamura N; Torigoe T; Heike Y
Cancer Sci; 2020 Aug; 111(8):3057-3070. PubMed ID: 32495519
[TBL] [Abstract][Full Text] [Related]
40. Class I major histocompatibility complex antigens and tumor ploidy in breast and bronchogenic carcinomas.
Redondo M; Concha A; Ruiz-Cabello F; Morell M; Esteban F; Talavera P; Garrido F
Cancer Detect Prev; 1997; 21(1):22-8. PubMed ID: 9043759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
